Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?
10:19am, Friday, 17'th Oct 2025
President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockbuster drug Ozempic from around $1,300 to
What's Behind The Slump In Pfizer Stock?
09:55am, Friday, 17'th Oct 2025
Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped
ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million
03:27pm, Thursday, 16'th Oct 2025
On October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV disclosed in an SEC filing that it sold out of Pfizer (PFE -0.57%) , with an estimated $2.66 million trade.
QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market
11:35am, Thursday, 16'th Oct 2025
On Thursday, QSM Asset Management disclosed a significant buy of Pfizer (PFE -0.04%), adding shares worth an estimated $6.8 million in the third quarter.
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
08:12am, Thursday, 16'th Oct 2025
Over the past decade, pharmaceutical maker Pfizer (PFE -0.53%) has severely lagged the market. Dividends reinvested aside, the stock is in the red over this period, while the S&P 500 is up by almost
Pfizer: Don't Forget About Value During AI Frenzy
05:08am, Thursday, 16'th Oct 2025
Pfizer is rated a Strong Buy, offering a nearly 7% forward dividend yield, which is highly likely safe. PFE's revenue has stabilized, management is delivering cost savings, and a recent drug pricing d
CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
03:31pm, Wednesday, 15'th Oct 2025
Wells Fargo CEO Charlie Scharf said AI is boosting productivity but will likely reduce workforce size. Pfizer CEO Albert Bourla warned China is closing the biotech and pharmaceutical patent gap rapidl
Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026?
09:41am, Wednesday, 15'th Oct 2025
Big Pharma reignites dealmaking as Pfizer, Novo Nordisk and Roche target obesity and metabolic diseases in a high-stakes 2025 M&A surge.
Pfizer CEO says US pharma industry needs to collaborate with China
10:58pm, Tuesday, 14'th Oct 2025
Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China's, where speedy processes have vaulted it to 30% of global drug development o
Top Dividend Stocks Delivering Over 5% for True Financial Freedom
02:45pm, Tuesday, 14'th Oct 2025
It is possible to achieve financial freedom through stock investing. If you pick the right companies, stay invested for the long term, and reinvest the dividends, you can build a solid portfolio for r
3 Sizzling Ultra-High-Yield Stocks Under $50 With Upside Potential
10:45am, Tuesday, 14'th Oct 2025
Investors can have their higher yields and capital appreciation potential, too. But, of course, there are always added risks to consider, and when it comes to the hard-hit higher-yielders out there, t
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor TUK
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:00am, Monday, 13'th Oct 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Where Will Pfizer Be in 5 Years?
08:45am, Monday, 13'th Oct 2025
The 6.7% dividend yield on offer from Pfizer (PFE -1.72%) is both a sign of opportunity and risk. A lot will happen over the next five years that will determine if that dividend is sustainable.
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
06:45am, Monday, 13'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) will present data across its infectious disease portfolio at the upcoming IDWeek 2025 congress, held in Atlanta from October 19-22, 202
